Teva Buys Allergan Unit: How Mylan, Other Biotech Stocks Are …

Related TEVATeva Still A ‘Must-Own’ Stock, Worth $86Benzinga’s Top UpgradesWeekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA(GuruFocus)Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) surged to new 52-week highs of $69.42 on Monday after the company announced its acquisition of Allergan PLC (NYSE: AGN)’s Generics segment for a total consideration of $40.5 billion.Shares of Allergan also spiked to new […]